SHA:600380 Market Cap

SHA:600380 has a market cap or net worth of 17.4 billion as of June 29, 2026. Its market cap has decreased by -14.69% in one year.

Market Cap

17.40B

Enterprise Value

15.54B

Revenue

14.85B

Ranking

n/a

PE Ratio

13.40

Stock Price

9.75

Market Cap Chart

Since June 8, 2001, SHA:600380's market cap has increased from 11.33B to 17.40B, an increase of 53.60%. That is a compound annual growth rate of 1.73%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	17.40B	-17.65%
Dec 31, 2025	21.13B	0.04%
Dec 31, 2024	21.12B	-8.85%
Dec 29, 2023	23.17B	10.03%
Dec 30, 2022	21.06B	-12.30%
Dec 31, 2021	24.02B	-10.62%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Walvax Biotechnology	18.66B
Jiangsu Nhwa Pharmaceutical Co., LTD	18.52B
Chengdu Kanghong Pharmaceutical Group	17.98B
Apeloa Pharmaceutical Co.,Ltd	17.97B
Hybio Pharmaceutical	17.46B
Dizal (Jiangsu) Pharmaceutical	16.97B
Kangmei Pharmaceutical	16.73B
China Resources Double-Crane Pharmaceutical	16.11B

Market Cap Rankings